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Protein arginine methyltransferase 4 (PRMT4) is an essential epigenetic
regulator of fundamental and conserved processes during vertebrate devel-
opment, such as pluripotency and differentiation. Surprisingly, PRMT4
homologs have been identified in nearly all vertebrate classes except the
avian genome. This raises the possibility that in birds PRMT4 functions
are taken over by other PRMT family members. Here, we reveal the exis-
tence of a bona fide PRMT4 homolog in the chicken, Gallus gallus. Using a
biochemical approach, we initially purified a putative chicken PRMT4 pro-
tein and thus provided the first evidence for the presence of an endogenous
PRMT4-specific enzymatic activity toward histone H3 arginine 17 (H3R17)
in avian cells. We then isolated a G. gallus PRMT4 (ggPRMT4) transcript
encompassing the complete open reading frame. Recombinant ggPRMT4
possesses intrinsic methyltransferase activity toward H3R17. CRISPR/
Cas9-mediated deletion of ggPRMT4 demonstrated that the transcript
identified here encodes avian PRMT4. Combining protein–protein docking
and homology modeling based on published crystal structures of murine
PRMT4, we found a strong structural similarity of the catalytic core
domain between chicken and mammalian PRMT4. Strikingly, in silico
structural comparison of the N-terminal Pleckstrin homology (PH) domain
of avian and murine PRMT4 identified strictly conserved amino acids that
are involved in an interaction interface toward the catalytic core domain,
facilitating for the first time a prediction of the relative spatial arrangement
of these two domains. Our novel findings are particularly exciting in light
of the essential function of the PH domain in substrate recognition and
methylation by PRMT4.
Protein arginine methyltransferases (PRMTs) comprise
an enzyme family that post-translationally modifies a
multitude of nuclear and cytoplasmic proteins. These
enzymes transfer a methyl group from the ubiquitous
cofactor S-adenosyl-L-methionine (SAM) to the
terminal guanidino nitrogens of arginine residues in
their substrate proteins. Subsequent to the formation
of monomethyl arginine (MMA) as an intermediate,
type I PRMTs generate asymmetric (x-NG,x-NG)
dimethyl arginine (ADMA), whereas type II enzymes
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give rise to symmetric (x-NG,x-N’G) dimethyl arginine
(SDMA) [1]. In mammals, nine PRMTs (PRMT1-9)
have been identified, which regulate a wide range of
cellular functions, for example, signal transduction,
nucleocytoplasmic transport, transcription, RNA pro-
cessing, and DNA repair. Given the involvement of
PRMTs in essential processes of eukaryotic physiol-
ogy, the enzyme family and its modifications are
believed to be ancient in evolution. Consistently, phy-
logenetic searches for PRMT homologs in nonmam-
malian animals revealed that PRMTs can be found in
nearly all groups of eukaryotes. PRMT1 and PRMT5,
which catalyze the majority of ADMA and SDMA
production, respectively, are both present across every
eukaryote species studied, whereas the distribution of
other PRMT members seems to be restricted [2,3]. For
example, PRMT4, also named CARM1 (coactivator-
associated arginine methyltransferase 1), was detected
in most invertebrates with more than 70% sequence
identity, but absent from the genome of nematodes.
Furthermore, PRMT4 was found conserved with a
high degree (>90%) of sequence identity in all verte-
brate classes except the avian genome [2].
PRMT4 was the first PRMT member functionally
linked to epigenetic regulation through asymmetric
dimethylation of histone H3 [4]. Several transcription
factors, such as steroid hormone receptors, STAT5
and c-MYB, that interact with PRMT4 have been
reported to place the enzyme close to chromatin and
nucleosomal H3 [1,5–7]. Subsequently, PRMT4-
mediated methylation of arginine 17, 26, and 42 in H3
promotes transcription. As an example, asymmetric
dimethylation of H3R17 (H3R17me2a) is recognized
by the TUDOR domain-containing coactivator
TDRD3 and furthermore facilitates chromatin recruit-
ment of the transcription elongation-associated com-
plex PAF1 [8,9]. Additionally, the nontail modification
H3R42me2a destabilizes nucleosomes due to weaken-
ing of the interaction between the histone octamer and
DNA [10]. Apart from histone H3, PRMT4 modifies
also other nuclear proteins, such as transcription fac-
tors, the coregulators p160 and CBP/p300, the media-
tor subunit MED12, and the C-terminal domain of
RNA polymerase II, thereby exerting transcriptional
coactivating as well as corepressing functions [11–16].
Mice lacking PRMT4 die perinatally due to lung
dysfunction and exhibit further developmental defects
compared to their wild-type littermates [17,18].
Enzyme-dead-knockin mice show deficiencies similar
to those seen in the knockout mice, indicating that
the catalytic domain of PRMT4 is essential for most
of its in vivo functions [19]. Detailed analyses of the
biological relevance of PRMT4 revealed that the
enzyme is required for pluripotency and self-renewal
of stem cells and progenitor cells as well as for cell
fate and differentiation decisions in various organs,
such as the immune system, muscle, and adipose tis-
sue [7,20–24].
Consistent with reports showing that PRMT4 is
highly expressed in immune cells and controls their dif-
ferentiation as well as activation on gene expression
level [25], we recently found that PRMT4 interacts
with the transcription factor c-MYB in human
hematopoietic cells and coactivates c-MYB-dependent
target gene expression in cooperation with the chro-
matin remodelers Mi2a/b [7]. C-MYB is a key regula-
tor of vertebrate hematopoiesis and predominantly
expressed in immature hematopoietic cells regulating
the proliferation and differentiation of stem as well as
progenitor cells [26]. Initially, MYB was identified as a
retroviral oncoprotein of avian leukemia viruses indi-
cating its functional conservation in birds [27,28].
Interestingly, we observed that in chicken macro-
phages c-MYB-dependent transcription is coactivated
upon overexpression of mammalian PRMT4, suggest-
ing that the enzyme and its function might have
evolved together with the interaction partner c-MYB
and various substrates, such as H3R17, also in the
avian lineage [7]. Given that a BLAST search of the
currently available Gallus gallus genome fails to iden-
tify a PRMT4 homolog, we raised the question
whether avian PRMT4 exists. A biochemical approach
enabled the isolation of the putative chicken ortholog
on protein level and provided the first evidence for the
presence of endogenous enzymatic activity of PRMT4
in avian cells. Sequence homology searches using the
human PRMT4 cDNA as query and a subsequent
multistep cloning strategy resulted in the identification
of a G. gallus PRMT4 (ggPRMT4) transcript encom-
passing the complete ORF. The avian ortholog shows
more than 90% sequence identity with human PRMT4
and possesses intrinsic catalytic activity toward
H3R17. We used the published crystal structure of
murine PRMT4 for protein modeling of chicken
PRMT4. The overall high sequence identity between
chicken and mammalian PRMT4 leads to a predicted
high structural similarity, yet with avian-specific
variations in the Pleckstrin homology (PH) domain.
In silico analyses of the relative spatial arrangement of
the PH and the catalytic domain provided for the first
time a prediction of the interaction interface between
these two domains. Strictly conserved amino acids
within the PH domain of birds and other vertebrates
are responsible for this interface establishing the struc-
tural basis for the essential catalytic functions of the
PH domain.
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Materials and methods
Cell lines
HD11 chicken macrophages were maintained in Iscove’s
modified Dulbecco’s medium (Gibco, Thermo Scientific)
supplemented with 8% FBS (Gibco) and 2% chicken serum
(Sigma Aldrich) at 37 °C and 5% CO2. Sf9 cells were cul-
tured in Sf-900TM II SFM medium (Gibco) and maintained
at 27 °C and 90 r.p.m.
RNA isolation, cDNA synthesis, and PCR
amplification
Total RNA from HD11 cells was isolated using the Peq-
Gold total RNA Kit (PeqLab). For first-strand cDNA syn-
thesis, 500 lM oligo(dT)17 primers was annealed to 2 lg of
total RNA at 70 °C for 10 min prior to the addition of
reaction buffer (20 mM Tris pH 8.5, 50 mM KCl, 10 mM
DTT, 500 lM dNTPs, and 25 mM MgCl2). Following
5 min of incubation at 42 °C, 200 U SuperScript II reverse
transcriptase (Thermo Scientific) and 20 U RiboLock
RNase inhibitor (Thermo Scientific) were added and incu-
bated for 90 min at 42 °C. After inactivation at 70 °C for
15 min, RNA was digested using 5 U RNase H (NEB) for
20 min at 37 °C. Subsequently, 0.75 lL of cDNA was sub-
jected to PCR amplification using 1 U Phusion polymerase
(Thermo Scientific), 500 nM of various PRMT4 homology
primers (listed below), 500 lM dNTPs, and 2% DMSO. To
maximize the PCR product yield, touch-down PCR was
applied with annealing temperatures ranging from 64 °C to
55 °C in addition to the standard Phusion polymerase pro-
gram. The following primers were employed for cDNA
amplification:
Forward ggEST#1 50-GCCAACGAGAGAGTCCAAC-30
Forward ggEST #2 50-TTCCAGTTCTACGGGTACCTCTC-30
Forward ggEST #3 50-AATCGTCGGCTGTGCAGT-30








Identification and amplification of ggESTs and
full-length ggPRMT4 transcript
Human PRMT4 mRNA (NCBI ref seq: NM_199141.1)
was used as a query sequence for a Nucleotide Basic
Local Alignment Search (BLAST, NCBI) of the G. gallus
expressed sequence tag (EST) database. Therefore, two
cDNA clones ChEST394e4 and ChEST665c21 were identi-
fied. To receive additional sequence information of the
50- and 30-end of the putative ggPRMT4 transcript, a
forward primer encompassing the start codon of human
PRMT4 was combined in touch-down PCR with the
reverse primer that binds the 30-end of the previously
identified G. gallus cDNA fragment. Therefore, an addi-
tional 74-bp fragment was identified from the cDNA of
HD11 cells, which included a start codon and 22 bp of
the 50-UTR sequence of the putative chicken PRMT4
ortholog. To obtain also the 30-end sequence information
of ggPRMT4 mRNA, various reptile cDNA sequences
were extracted from the NCBI nucleotide database and
subjected to multiple sequence alignments with the MUS-
CLE tool. Based on the most frequent nucleotides at each
position, a reptile homology reverse primer was designed.
This reverse primer was applied together with a forward
primer encompassing the ATG of ggPRMT4 and resulted
in an amplicon of 2000 bp from HD11 cDNA providing
the remaining 450 bp of coding sequence of the 30-end
including the stop codon and an additional 220-bp
sequence of the 30-UTR. Accuracy of the resulting full-
length coding sequence of the chicken PRMT4 transcript
was confirmed by three independent rounds of RNA iso-
lation, cDNA amplification, and Sanger sequencing (LGC
Genomics)
of both strands. The complete G. gallus PRMT4 transcript
has been deposited in the GenBank database with
accession number KY655811.
siRNAs
Small interfering RNAs (siRNAs) were purchased from
Dharmacon or Eurogentec. The sequences of the control
siRNAs were provided by Dharmacon. The sense strands
of the various siRNAs are indicated below.
siCtrl.1 50- AUGAACGUGAAUUGCUCAA -30
siCtrl.2 50- UGGUUUACAUGUCGACUAA-30
siEST.1 50- GCUGUGCAGUACUUCCAGU -30
siEST.2 50- UCAUCAUCUCGGAGCCCAU -30
Plasmids and clonings
The following plasmids were used for baculoviral expres-
sion in Sf9 cells: pFASTBAC-flag-mmPRMT4 was pub-
lished by [12]. The complete ORF of ggPRMT4 (aa 1-580)
was amplified by mutagenesis PCR (forward primer:
50-TATAGAATTCATGGCGGCGGTG-30, reverse primer:
50-GACCCTCGAGTCAGCTGCCGTAGTGC-30) and
inserted via EcoRI and XhoI into the pFASTBAC HT A
vector (Invitrogen). Further, this EcoRI/XhoI fragment of
ggPRMT4 cDNA was cloned into pGEX4T1 vector (Sigma
Aldrich) for expression of GST-tagged full-length
ggPRMT4 in E. coli. The plasmid encoding GST-tagged
full-length mmPRMT4 was published in [7]. The plasmid
pCMV-Tag2-flag-rPRMT4 [29] was used for overexpression
of mammalian PRMT4 in HD11 cells.
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The following target sites in ggPRMT4 or GFP as con-











Pairs of oligos for these targeting sites (including the
PAM sequence) were annealed and cloned into BsmBI-
restricted lentiCRISPRv1 plasmid (Addgene), which
enables bicistronic expression of Cas9 and gRNA.
Transfections and infections
6 9 106 HD11 cells per 15-cm dish were transiently trans-
fected with 50 lg plasmids using a standard CaPO4 trans-
fection protocol. For siRNA transfections, HD11 cells
(2.4 9 106 cells per 10-cm dish) were transfected with
20 lM siRNA using Metafectene Pro (Biontex) according
to the manufacturer’s protocol.
For CRISPR/Cas9-mediated deletion of ggPRMT4 in
HD11 cells, HEK293T cells were transfected with the two
packaging plasmids pMD2.G and psPAX2 together with
the lentiviral expression plasmid lentiCRISPRv1 encoding
the gRNA/controls and Cas9. Transfections were per-
formed using X-tremeGENE (Roche). Supernatants con-
taining lentiviral particles were harvested one and 2 days
after transfection and concentrated using PEG. For infec-
tion, 1.5 9 106 HD11 cells per 10-cm dish were seeded. At
the next day, cells were infected in the presence of poly-
brene (8 lgmL1) with viruses encoding either the combi-
nation of all three ggPRMT4 gRNAs or the GFP control
gRNA. Cells were selected using puromycin and after single
cell cloning maintained in the presence of 1 lgmL1
puromycin.
Recombinant baculoviruses were generated according
to the Bac-to-Bac baculovirus system (Invitrogen). After
one round of virus amplification, 20 9 106 Sf9 insect
cells per 15-cm dish were infected with 7.5 lL virus/106
cells.
Antibodies
The following antibodies were used in western blot,
immunofluorescence staining, and immunoprecipitation:
Rabbit affinity-purified anti-murine PRMT4 was produced
using His-tagged recombinant protein corresponding to aa
433-608 of murine PRMT4 [7], anti-human PRMT4 (09-
818, Merck Millipore, epitope aa 595-608), anti-b-tubulin
(MAB3408, Merck Millipore), anti-H3R17me2a (ab8284,
Abcam), anti-H3 (ab1791, Abcam), anti-ADMA (13522,
Cell Signaling), anti-Flag (F 3165, Sigma Aldrich), and
anti-rabbit IgG (I5006-10MG, Sigma Aldrich).
Immunofluorescence staining
HD11 cells (1.3 x 105 /24 well) were plated on cover slips.
After 24 h, cells were rinsed in PBS and fixed in methanol
for 10 min at 20 °C. Subsequently, cells were washed in
PBS, permeabilized in PBS/0.3% Triton X-100 for 5 min,
and blocked in PBS/4% BSA for 45 min. Then, cells were
stained with the indicated antibodies in the presence of
PBS/4% BSA for 2 h at room temperature. Afterward,
cells were rinsed three times in PBS and stained with the
secondary antibody anti-rabbit Cy3 (Jackson Immuno
Research) for 1 h at room temperature in the presence of
0.14 lgmL1 DAPI (40,6-diamidino-20-phenylindole-dihy-
drochloride) for nuclear/DNA staining. After the final
washes in PBS, cells were mounted (Mowiol containing
25 mgmL1 DAPCO) and analyzed by fluorescence micro-
scopy (Axioskop 2, Zeiss).
Immunoprecipitation
For whole-cell extracts (WCE), Flag-PRMT4-transfected
and wt HD11 cells were washed with ice-cold PBS and
lysed in IPH buffer (50 mM Tris/HCl pH 8.0, 200 mM
NaCl, 0.5% NP-40, 5 mM EDTA, protease inhibitors) fol-
lowed by treatment with 62.5 U Benzonase (Invitrogen) per
mg protein lysate in the presence of 7.5 mM MgCl2 for 1 h
at 4 °C to digest genomic DNA. Extracts were cleared by
centrifugation. For subsequent immunoprecipitation, 1 mg
WCE per IP was adjusted to 150 mM NaCl in a total vol-
ume of 1 mL. The extracts were incubated with 4 lg of the
indicated antibodies overnight at 4 °C and then BSA-
blocked protein G agarose (GE Healthcare) was added for
2 h at 4 °C. The bead-bound precipitates were subjected to
extensive washes using cold IPH buffer and finally
employed in western blot or methyltransferase (MT) assays.
Recombinant protein preparation
GST-tagged proteins were purified from E. coli BL21,
eluted from glutathione Sepharose (GE Healthcare) in the
presence of 50 mM Tris pH 8.0 including 25 mM reduced
glutathione and finally dialyzed (PBS, 10% glycerol) using
standard protocols. For protein preparation of recombinant
Flag-tagged mmPRMT4 and His-tagged ggPRMT4, bac-
ulovirus-infected Sf9 cells were washed twice with PBS
prior to 39 freeze and thaw lysis in BC buffer (20 mM
HEPES pH 7.9, 250 mM NaCl, 10% glycerin, 0.4 mM
EDTA, 1 mM b-mercaptoethanol, and 1 mM PMSF). Pro-
tein purification was performed using Ni-NTA Sepharose
(Qiagen) and anti-Flag M2 Affinity Gel (Sigma Aldrich) as
previously described [30]. The concentration of
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recombinant proteins was determined by SDS/PAGE and
Coomassie staining.
Methyltransferase (MT) assays
For in vitro methyltransferase (MT) assays, 4-16 lg of
either bulk histones from calf thymus (Sigma Aldrich),
purified core histones from calf thymus (Roche) or H3 pep-
tides (aa 1-25 amino acids synthesized by Peptide Specialty
Laboratories Heidelberg, Germany) was incubated with
precipitates from HD11 cells (bead-bound PRMT4) or 1–
2 lg of purified recombinant GST-, Flag-, or His-tagged
PRMT4 and 2 lL [14C-methyl]-SAM (58.3 nCi mM 1, Per-
kin Elmer) in PBS for 3–12 h at 30–37 °C. Subsequently,
the reactions were separated by SDS/PAGE, blotted, and
analyzed by autoradiography.
In silico model building
The protein–protein docking was performed using ZDock
3.0.2 [31]. The crystal structures 2OQB and 3B3F were used
as input structures (Table S1). PDB ID 3B3F was chosen
because it comprises two homodimers, which could be
selected as one docking partner without altering the PDB
file beforehand, to facilitate a maximally unbiased docking.
To introduce random variations in the docking, four calcu-
lations were performed. In those calculations, the combina-
tions of the chains of both input structures were
permutated (3B3F [AB/CD], 2OQB [A/B]). A binding pose
comprising nice shape complementarity and recurring in all
four dockings within the first six solutions was chosen for
further modeling.
Homology modeling was performed using MODELLER
9v14 [32]. For modeling the PH domain of PRMT4, the
homolog from Mus musculus (PDB ID 2OQB) was used.
The cofactor- and substrate-binding domains were also
modeled using PRMT4 from M. musculus (PDB ID 3B3J).
Prior to model building, target and template sequences
were aligned using MODELLER. For further refinement,
the model for the PH domain was chosen according to the
discrete optimized protein energy (DOPE) score. For the
cofactor- and substrate-binding domains, one model was
duplicated and combined with the model of the dimer
afterward.
The modeled domains were aligned to the results of the
docking in PyMOL [33] and thereafter protonated and min-
imized in MOE [34], followed by an optimization of the
docking poses using the Docking2 Rosetta Protocol with
the ‘docking-local-refine’ option enabled [35–37]. The
model was then subjected to a 50-ns molecular dynamics
simulation using Amber 14 [38] utilizing the ff99SB force
field [39] to allow for larger-scale relaxation of the relative
orientation, followed by a final short geometry minimiza-
tion for bond lengths, bond angles, and planarity using
Phenix 1.10.1-2155 [40]. The final model was evaluated with
WHAT_IF [41] version WHATCHECK 7.0 and PRO-
CHECK v.3.5 [42]. Ramachandran plot outliers were,
where possible, manually corrected altering the dihedrals of
the corresponding residues in Coot [43]. The final
Ramachandran plot is shown in Fig. S3.
Results and Discussion
Detection of endogenous PRMT4 protein and
enzymatic activity in avian cells
Recent observations indicate that c-MYB-dependent
transcription is coactivated by PRMT4 in mammalian
as well as avian cells [7], suggesting that the enzyme and
its function are evolutionarily conserved also in the bird
lineage. As PRMT4 has been found in all vertebrate
classes with the exception of birds [2], we searched for
the presence of endogenous enzymatic activity of
PRMT4 in chicken cells. In a first step, we used anti-
bodies generated in our laboratory against murine
PRMT4 [7] and performed immunoprecipitations from
extracts of HD11 cells, a chicken macrophage cell line.
Input and precipitates were immunoblotted with a sec-
ond commercially available anti-human PRMT4 anti-
body, which displayed the recognition of a 68-kDa
protein band, that is, within the expected molecular
weight range of a putative chicken PRMT4 ortholog
(Fig. 1A). Control antibodies did not precipitate this
protein band (Fig. 1A). Next, we employed these pre-
cipitates in in vitro methyltransferase (MT) assays using
14C-radiolabeled SAM and either unmodified histone
H3 peptides or premodified at R17 (R17me2a). By
autoradiography, we detected an enzymatic activity
specific for H3R17 in chicken, as the anti-PRMT4 pre-
cipitates exhibited methylation activity toward the
unmodified but not premodified peptides (Fig. 1B).
Control precipitates did not show any detectable enzy-
matic activity (Fig. 1B). H3R17 is a nonredundant and
major methylation target of mammalian PRMT4 [5,44].
As a control, we immunoprecipitated overexpressed
Flag-tagged murine PRMT4 from HD11 cell extracts
and utilized the Flag precipitates in in vitro MT assays
showing R17 methylation (Fig. S1). Collectively, these
initial results provided the first experimental evidence
for the existence of PRMT4 protein and activity in
avian cells.
Identification of expressed sequence tags (ESTs)
in Gallus gallus with sequence similarity to
human PRMT4
In the next step, the human PRMT4 cDNA sequence
(NM_199141.1) was employed as query sequence to
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search the G. gallus expressed sequence tag (EST)
database for the putative chicken ortholog. Two par-
tial chicken ESTs (chEST394e4 and chEST665c21)
were found that exhibit significant sequence homology
(83–85% identity) to the human PRMT4 transcript
and encoded the putative PH (Pleckstrin homology)
domain, SAM-binding domain and N-terminal part of
the substrate-binding domain (Fig. 2A). As these ESTs
overlapped across a 500-bp segment sharing a
sequence identity of 98%, we assumed that they derive
from a single gene. For further investigation, we per-
formed reverse transcription (RT)-PCR employing
RNA isolated from HD11 cells and several forward
primers (Fig. 2A, #1 - #4), complementary to both
ESTs or only the 50-end of chEST394e4, in combina-
tion with a reverse primer complementary to the
30-end of chEST665c21 (Fig. 2A). The resulting
amplicons showed the expected sizes, in particular also
an approximately 1000-bp PCR fragment spanning
both ESTs (Fig. 2B, #1), indicating that the ESTs
indeed originate from a single gene. Sanger sequencing
analysis of these amplicons verified the EST sequences
and their homology to the human PRMT4 transcript.
Next, we designed two alternative siRNA molecules
(siEST.1 and siEST.2) based on this partial mRNA
and transfected them into HD11 cells. Compared to
control siRNA transfections, both siESTs resulted in
reduced western blot detection of the 68-kDa putative
PRMT4 protein band by antibodies recognizing
human PRMT4 (Fig. 2C). Furthermore, the levels of
H3R17me2a and ADMA decreased upon siEST trans-
fection in the chicken cell extracts (Fig. 2C). These
results identified ESTs in G. gallus with high sequence
similarity to human PRMT4 and confirmed the
connection between the predicted PRMT4 transcript
and the putative PRMT4 protein in avian cells.
Cloning of the complete CDS and parts of the
UTR sequences of Gallus gallus PRMT4
To receive additional sequence information of the
50- and 30-end of the putative ggPRMT4 transcript, a
multistep cloning strategy was employed utilizing
homology primers derived from humans as well as rep-
tiles (the latter as the phylogenetically closest relatives
of birds). This approach resulted in the isolation of a
G. gallus PRMT4 (ggPRMT4) transcript encompassing
the complete coding sequence, which has not been
annotated in the currently available G. gallus genome
(Ensembl Gallus_gallus-5.0, last updated/patched-Dec
2016). The ggPRMT4 mRNA is 1743 bp in length and
encodes a 580-amino acid protein (Fig. 3). The corre-
sponding protein shares more than 90% sequence
identity with human PRMT4. Likewise, the epitopes
of the antibodies recognizing murine and human
PRMT4, which were employed in the detection of
putative chicken PRMT4 protein (Fig. 1), are highly
conserved in ggPRMT4 (Fig. 3). In agreement, these
mammalian-specific PRMT4 antibodies detected
recombinant chicken PRMT4 proteins (Fig. S2).
Alignment of ggPRMT4 and several representative
vertebrate PRMT4 proteins revealed a high sequence
conservation in the catalytic core domain and particu-
larly in the four PRMT signature motifs of the cofac-
tor- and substrate-binding module, which are identical
in sequence for the presented vertebrate species (Fig. 3,
gray boxes). Similarly, the methyltransferase motifs I,
Post I, II, III, and the THW loop are highly
Fig. 1. Detection of endogenous PRMT4 protein and catalytic activity in chicken cells. (A) Whole-cell extracts from HD11 cells (1 mg) were
subjected to immunoprecipitation (IP) of endogenous, putative chicken PRMT4 protein using antibodies specific for murine PRMT4 (a-
PRMT4, [7]). IPs using isotype control IgG (a-Ctrl) were performed as negative control in parallel. Input (10%) and IP reactions were
analyzed by western blot using a commercial human PRMT4 antibody (Merck Millipore). The arrow indicates the 68-kDa putative PRMT4
protein band in chicken cells. The asterisk marks the IgG heavy chain. (B) IPs from HD11 cells were performed using antibodies specific for
murine PRMT4 (a-PRMT4) and isotype control IgG (a-Ctrl), as described in A. Precipitates were subjected to in vitro methyltransferase (MT)
assays (overnight, at 30 °C) in the presence of either unmodified or R17me2a-premodified H3 peptides (aa 1-25) and in the absence () or
presence (+) of 14C-labeled SAM. Methylation products were resolved by SDS/PAGE, blotted, and analyzed by autoradiography (upper
panel). The arrow indicates the histone H3 peptide band. Immunostaining of the blot with PRMT4 antibodies (a-PRMT4) visualizes the bead-
bound PRMT4 used in the methylation assay as an input control (lower panel).
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conserved. Outside the catalytic core, significant diver-
sity was observed in the N- and C-terminal sequences.
For example, the first 25 amino acids, which have been
predicted to be highly disordered in murine PRMT4,
are specific for the mammalian homologs and are lost
in the avian as well as in reptile lineage (Fig. 3),
suggesting that this region might not contribute to
essential functions of PRMT4 [45]. In contrast, the
N-terminal Pleckstrin homology (PH) domain and the
C-terminal transactivation domain (TAD), which are
unique for PRMT4 within the PRMT family, are
found with some sequence variations also in the avian
homolog. Both domains are required for coactivator
function and substrate specificity of PRMT4 [46,47].
As an example, the automethylation site R548 within
the TAD is strictly conserved among all vertebrate
species including birds, indicating an evolutionary
preserved and essential function of this residue for
self-regulation of PRMT4 in pre-mRNA splicing and
transcriptional activation [48]. Altogether, these results
identify the complete open reading frame (ORF) of
G. gallus PRMT4 with high sequence similarity to
other vertebrate homologs.
Intrinsic methyltransferase activity of
recombinant Gallus gallus PRMT4 toward
histone H3R17 and other cellular proteins
To confirm that the newly obtained ORF codes for
the avian PRMT4 ortholog, we expressed GST-
Fig. 2. Identification of expressed sequence tags (ESTs) in Gallus gallus with high homology to human PRMT4 and encoding the expected
catalytic activity in chicken cells. (A) Schematic presentation of the Homo sapiens PRMT4 mRNA and two partially overlapping G. gallus
expressed sequence tags (ESTs), which were identified by nucleotide BLAST search using human PRMT4 mRNA as query sequence. Black
arrows indicate the translation start site, and colored boxes mark segments that translate into functional domains. Abbreviation of the
functional domains: PH: Pleckstrin homology domain (green); SAM-BD: S-adenosyl-methionine-binding domain (dark blue); substrate-BD:
substrate-binding domain (purple); TAD: transactivation domain (light blue). PCR primers used for amplification of the EST sequences from
G. gallus cDNA (in B) are illustrated by gray arrows (bright gray: forward primers no. 1–4, dark gray: reverse primer). (B) Total RNA from
HD11 cells was reverse-transcribed by oligo(dT) priming and subsequently amplified by standard touch-down PCR using the indicated
forward primers in combination with the constant reverse primer (illustrated in A). PCR products were separated via agarose gel
electrophoresis, excised, purified, and subjected to Sanger nucleotide sequence analysis. (C) HD11 cells were transfected with either
nontargeting control siRNAs (siCtrl.1 and siCtrl.2) or two alternative siRNAs derived from the G. gallus EST sequences (in A) targeting
putative chicken PRMT4 (siEST.1 and siEST.2). 72 h post-transfection, whole-cell extracts were prepared and analyzed by western blot
using the indicated antibodies (a-PRMT4, a-H3R17me2a and a-ADMA). Immunostaining with antibodies against histone H3 and b-tubulin
served as loading controls. Molecular weights of the protein marker bands are indicated on the left.
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tagged full-length ggPRMT4 in bacteria and assayed
the purified fusion protein for methyltransferase
activity using purified histones H3 and H4 as well
as bulk histones as substrates. These in vitro MT
assays demonstrated that the recombinant protein
intrinsically possesses catalytic activity and methy-
lates specifically histone H3, but no other core his-
tone, whereas GST alone did not show any
methyltransferase activity (Fig. 4A). Given that bac-
terially expressed GST-PRMTs are less active, in
particular on peptide substrates, than recombinant
PRMTs purified from insect cells (our own observa-
tion, data not shown), we established the bac-
ulovirus-mediated expression in Sf9 cells and
purification of His-tagged full-length ggPRMT4. This
His-tagged ggPRMT4 revealed that the enzyme
specifically methylates R17 in histone H3, the well-
known methylation site of mammalian PRMT4
(Fig. 4B). To finally show that the gene, from which
this newly identified PRMT4 transcript derives, is
responsible for the catalytic activity in chicken cells,
we designed guide RNAs targeting the ggPRMT4
coding sequence (within the PH domain), as no
information on the genomic location of PRMT4 is
available due to its hitherto missing annotation in
the G. gallus genome. Consequential CRISPR/Cas9-
mediated deletion of ggPRMT4 in HD11 cells
resulted in a complete loss of nuclear PRMT4 as
well as H3R17me2a detection by immunofluorescence
staining compared to control cells (Fig. 4C). Further-
more, the in vivo activity of the avian homolog was
verified by the global loss of arginine-methylated
proteins in PRMT4-knockout compared to control
HD11 cells, as examined by western blot using
ADMA antibodies (Fig. 4D). These results unam-
biguously show that the transcript identified here
encodes a catalytically active arginine methyltrans-
ferase with the substrate specificity of PRMT4 and
eventually confirms the existence of a PRMT4 ortho-
log in the bird lineage.
In silico modeling of the three-dimensional
protein structure of Gallus gallus PRMT4
While the sequences of the cofactor- and substrate-
binding domains of PRMT4 are almost identical
among the vertebrate species, the N terminus encom-
passing the PH domain and the C terminus differ to
some extent in their sequences between the vertebrate
homologs (Fig. 3). Given that the PH domain has
recently been found to be responsible for substrate
recognition and methylation of most PRMT4
substrates in human cells [49], we investigated here the
sequence variations and conservations of chicken
versus other vertebrate PH domains to elucidate its
structural connection to the catalytic core domain and
how this might translate to its essential enzymatic
functions.
Although several crystal structures revealed the
dimeric arrangement of the central catalytic domain of
PRMT4, which is a structure commonly adopted by
all type I PRMTs, the full-length PRMT4 protein has
not been crystallized yet. In the only X-ray structure
published to date based on murine PRMT4 protein
encompassing aa 28-507, the N-terminal part (aa 28-
140) was disordered and therefore not visible (PDB ID
3B3J) [45]. Interestingly, the isolated N-terminal
domain (PRMT428-140) displayed a PH domain fold
(2OQB), which is known to mediate protein–protein
interactions and to bind proline-rich sequences [45].
However, the structural arrangement of this function-
ally essential domain relative to the entire PRMT4
dimer is still enigmatic. Therefore, we used the respec-
tive crystal structures from M. musculus and combined
protein–protein docking and homology modeling to
first dock the PH domains to the crystal structure of
the murine PRMT4 dimer and subsequently build a
homology model of the ggPRMT4 dimer including the
PH domains.
In the first step, the mmPH domain was docked to
the crystal structure of the catalytic core of
Fig. 3. Amino acid sequence alignment of Gallus gallus PRMT4 and several vertebrate PRMT4 orthologs. The nucleotide sequence of
G. gallus PRMT4 was translated using ExPASy translation tool and aligned with multiple vertebrate PRMT4 protein sequences using Clustal
Omega. Functional domains are highlighted (analogously to the color code in Fig. 2A) as follows: Pleckstrin homology domain (green),
S-adenosyl-methionine-binding domain (dark blue), substrate-binding domain (purple), and transactivation domain (light blue). The consensus
of the four signature sequences is underlined and written above. Rectangles encompass the conserved methyltransferase motifs I, Post I,
II, III, and the THW loop, which partially overlap with the signature sequences. The arrow marks the conserved arginine residue for PRMT4
automethylation. Residue numbering is shown on the right of the sequence. Asterisks mark fully conserved amino acid residues. Colons
indicate amino acid residues containing functional groups with strongly similar properties, while periods mark amino acids with weakly
similar features. Underlined amino acids in the human (aa 595-608) and murine (aa 433-608) sequence indicate the epitopes of the anti-
mammalian PRMT4 antibodies employed in this study. The accession numbers for the protein sequences used in this alignment are as
follows: G. gallus KY655811, Homo sapiens NP_954592.1, Mus musculus NP_067506.2, Anolis carolinensis XP_008102027.1, Thamnophis
sirtalis XP_013913272.1.
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Fig. 4. The Gallus gallus PRMT4 homolog is an arginine methyltransferase with substrate specificity for H3R17 in vitro and in vivo. (A)
Purified core histones H3 and H4 from calf thymus as well as bulk histones from calf thymus, as visualized in the Coomassie Blue-stained
SDS gel (left panel, molecular weight of the 15-kDa protein marker band is indicated), were subjected to in vitro MT assays in the presence
of purified, eluted GST protein alone, or GST-ggPRMT4 and 14C-labeled SAM. Methylation products were resolved on SDS/PAGE, blotted,
and visualized by autoradiography (right panel). The arrow indicates the histone H3 protein band. (B) Histone H3 peptides (aa 1-25,
unmodified or R17me2a) were subjected to in vitro MT assays in the absence () or presence (+) of recombinant His-tagged ggPRMT4 and
14C-labeled SAM. Coomassie Blue-stained SDS gel visualizes the baculoviral expressed, purified, and eluted His-tagged ggPRMT4 (left
panel, asterisk marks the PRMT4 protein band). Molecular weights of the protein marker bands are indicated on the left. Methylation
reactions were separated by SDS/PAGE, blotted, and visualized by autoradiography (right panel). The arrow indicates the histone H3 peptide
band. (C) CRISPR/Cas9-mediated PRMT4-knockout (PRMT4-KO) and control (Ctrl) HD11 cells were analyzed by immunofluorescence (IF)
staining for the levels and distribution of PRMT4 (a-PRMT4, upper panels) and histone H3R17 dimethylation (a-H3R17me2a, lower panels).
The corresponding DNA/nuclear stainings with DAPI are shown above. Right pictures represent higher magnifications of the framed areas of
the left pictures. All images were taken with the same exposure time. Scale bars indicate 200 lm and 20 lm, respectively. (D) Whole-cell
lysates of PRMT4-knockout (PRMT4-KO) and control (Ctrl) HD11 cells (as in C) were prepared and analyzed by western blot using the
indicated antibodies (a-PRMT4 and a-ADMA). Immunostainings with b-tubulin antibodies served as loading control. Molecular weights of the
protein marker bands are indicated on the left.
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mmPRMT4. Of the 36 existing crystal structures of
PRMT4 in the PDB archive, we used the structure of
mmPRMT4 with ID 3B3F, as it contains two homod-
imers in the unit cell, which can be selected as docking
targets (Table S1). In four independent, unbiased pro-
tein–protein docking calculations, a biophysically pos-
sible binding pose could be found among the ten
highest-ranked docking solutions, and all four of these
poses were similar to each other. This consensus pose
occurred on the top ranks (namely two, four, four,
and six, respectively) in each of the docking calcula-
tions. These four final docking poses are shown as an
overlay in Fig. 5A. Interestingly, the PH domains
cover the dimerization arms of the substrate-binding
domains, which is consistent with unhindered access to
the substrate- and cofactor-binding pockets.
Fig. 5. In silico modeling of the three-dimensional protein structure of Gallus gallus PRMT4. (A) Top view of the docking poses, which
shows the consensus docking pose selected for further modeling. The homodimer of the SAM- and substrate-binding domains is shown in
gray; the docking poses of the PH domains are shown in different shades of green. (B) Top view of the double helix formed by mmPRMT4
homodimers (gray) in the crystal structure of PDB ID 3B3J, generated by expanding the visualization in accordance with the hexagonal
space group of the crystal. The PH domain from PDB ID 2OQB (green) is modeled using the binding poses resulting from the docking
experiment. (C) Alignment of all 36 PRMT4 crystal structures deposited in the PDB archive until now (Table S1). Crystal structure 3B3J is
highlighted in cyan. The differing positioning of the N (blue sphere) and C termini (red spheres) is easily discernible. In this context, the
terms N terminus and C terminus refer to the last amino acid crystallographically resolved at the corresponding end of the protein sequence
used. 3B3J is the only structure in which N terminus and C terminus are located on the same side of the protein. (D) Final model of the
ggPRMT4 homodimer showing the spatial arrangement of the PH domains and the catalytic core domains (encompassing the SAM- and
substrate-binding domains). The domains are colored as follows: PH domain (green), SAM-binding domain (blue), and substrate-binding
domain (purple). The homodimer including the PH domains is shown in a top view in the left picture. The side view orientation in the right
picture is generated by rotating the first structure by 90° out of the paper plane followed by an approx. 60° rotation counterclockwise. In
this depiction, the interface between the PH domain and the catalytic core domain is highlighted with a dashed orange line. (E) The
sequence differences for the PH domain of PRMT4 between Mus musculus (2OQB) and G. gallus (homology model) are illustrated in the
modeled ggPH domain. The orientation is chosen in accordance with the orientation of the PH domain in the right picture of 5D. Sequence
differences are highlighted in yellow on the surface. In addition, the corresponding residues are shown in a yellow ball-and-stick
representation. The conserved amino acids of the putative interface are marked with a dashed orange line.
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Furthermore, although the PH domain was not
restrained to bind to a specific region of the dimer of
the cofactor- and substrate-binding domains, the C-
terminal residue of the PH domain in the model is
located in proximity to the N-terminal amino acid visi-
ble in the X-ray structure 3B3J [45], consistent with a
connection between them.
Inspecting the crystal structure 3B3J in more detail by
expanding the visualization in accordance with the
hexagonal space group P 62 2 2, it is striking how well
the PH domain in its docking pose occupies the empty
space in the protein crystal of mmPRMT4 (Fig. 5B).
Residues 28-140 were not resolved in X-ray structure
3B3J [45], but the arrangement of the remaining
domains and the packing of the protein in the crystal
can be regarded as a negative imprint of the location
and conformation of the PH domain and the disordered
C-terminal residues. The information that this void is
actually created by the presence of the unresolved resi-
dues was not used in our docking calculations and, thus,
the fact that the calculated arrangement perfectly fits
into this space strongly supports our prediction. It is
interesting to note that 3B3J is the only structure in
which the N and C termini are located on the same side
of the dimer, and in this way differs from any PRMT4
X-ray structure that is based on truncated versions of
the protein, that is, missing the PH domain (PRMT428-
140). In this vein, Yue et al. [47] compared PRMT4 with-
out (2V7E) and with cofactor (2V74) and found a differ-
ent orientation of the N terminus compared to 3B3J (no
cofactor). Troffer-Charlier et al. [45] obtained a differ-
ent arrangement in a second crystal structure of a cofac-
tor-free protein (3B3G). This evidence suggests that the
unique arrangement of the N-terminal amino acid in
3B3J is significantly induced by the presence of the N-
terminal PH domain and is not solely dependent on the
presence of the cofactor. An overview of the location of
N and C termini in the deposited PRMT4 crystal struc-
tures is depicted in Fig. 5C. Therefore, our findings indi-
cate the cause for the observed structural differences
between crystal structures 3B3J (without cofactor, but
crystallized with the PH domain) and 3B3G and 2V7E
(both crystallized without cofactor and without PH
domain).
Based on the docking results of mmPRMT4 compris-
ing the PH domain and the catalytic core, a homology
model of ggPRMT4 was generated (Fig. 5D). In our
approach, the PH domain and the cofactor- and
substrate-binding domains of ggPRMT4 were homology-
modeled independent of each other. The modeled
structures were fitted onto the corresponding units of the
docking-derived murine complex using PyMOL and
could be placed without violations of their structural
integrity, in line with a high structural similarity within
the catalytic core domain of the chicken and murine
PRMT4 homodimer, yet avian-specific variations in the
PH domain. An analysis of the putative interface between
the PH domain and the remaining PRMT4 homodimer
revealed that this interface region within the PH domain
is more conserved (between G. gallus and M. musculus)
than the rest of the domain. The putative interface in the
PH domain is formed by the concavely shaped ß-sheet at
the bottom of the domain (Fig. 5D). Interestingly, the
strictly conserved amino acids between the ggPH and
mmPH domains mediate inter- and intramolecular inter-
actions and are involved in the interface formation, as
illustrated in Fig. 5E for the ggPH domain. In contrast,
the variable amino acids are located at the surface of the
PH domain, thereby potentially accounting for minor
species-specific variations in the interaction domains of
PRMT4 binding partners in chicken. The coincidence of
the predicted interface with a conserved region of the PH
domain supports that the docking-derived binding mode
represents the actual interface.
Conclusions
Taken together, we identified here the avian ortholog of
PRMT4, which reveals more than 90% sequence iden-
tity with human PRMT4 and possesses the same sub-
strate specificity toward H3R17 as the other vertebrate
homologs. Based on published crystal structures of mur-
ine PRMT4 and combined protein–protein docking and
homology modeling, we predict a high structural simi-
larity between the mammalian and chicken PRMT4
protein consistent with their overall sequence conserva-
tion. Interestingly, our in silico structural comparison of
the N-terminal PH domain of chicken and murine
PRMT4 identified strictly conserved amino acids that
contribute to a newly predicted interaction interface
between the PH and the catalytic domain representing
the first forecast of their relative spatial arrangement.
Furthermore, these findings suggest a structural basis
for the recently reported essential functions of the PH
domain in substrate recognition and methylation by
PRMT4 [49]. Given the strict transspecies conservation
of the amino acids within the PH domain mediating the
interaction toward the catalytic core, we propose that
targeting this interface with small molecules could be a
promising strategy for the design of PRMT4-selective
inhibitors.
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